Dr. John Sarantopoulos, MD
Claim this profileUniversity of Texas Health Science Center at San Antonio
Studies Cancer
Studies Pancreatic Cancer
10 reported clinical trials
21 drugs studied
Area of expertise
1Cancer
Stage IV
PTEN positive
PIK3CA positive
2Pancreatic Cancer
Stage IV
PTEN positive
PIK3CA positive
Affiliated Hospitals
Clinical Trials John Sarantopoulos, MD is currently running
Bemcentinib + Pacritinib
for Lung Cancer
This is a Phase Ib/II, open-label, single institution dose-escalation, safety, pharmacokinetics, pharmacodynamic and efficacy study.
Recruiting1 award Phase 1 & 29 criteria
INV-9956
for Prostate Cancer
This is a Phase 1 and Phase 2 study to determine the safety profile, RDR and/or MTD, DLT, PK/PD, and preliminary antitumor activity of INV-9956 in adult patients with advanced mCRPC.
Recruiting1 award Phase 1 & 27 criteria
More about John Sarantopoulos, MD
Clinical Trial Related7 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments John Sarantopoulos, MD has experience with
- Pembrolizumab
- Afuresertib
- Prednisone
- LAE001
- INV-1120
- Oradoxel
Breakdown of trials John Sarantopoulos, MD has run
Cancer
Pancreatic Cancer
Prostate Cancer
Solid Tumors
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Sarantopoulos, MD specialize in?
John Sarantopoulos, MD focuses on Cancer and Pancreatic Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are PTEN positive.
Is John Sarantopoulos, MD currently recruiting for clinical trials?
Yes, John Sarantopoulos, MD is currently recruiting for 3 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that John Sarantopoulos, MD has studied deeply?
Yes, John Sarantopoulos, MD has studied treatments such as Pembrolizumab, Afuresertib, Prednisone.
What is the best way to schedule an appointment with John Sarantopoulos, MD?
Apply for one of the trials that John Sarantopoulos, MD is conducting.
What is the office address of John Sarantopoulos, MD?
The office of John Sarantopoulos, MD is located at: University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229 United States. This is the address for their practice at the University of Texas Health Science Center at San Antonio.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.